Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance ...

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...

GLASGOW, Scotland--(BUSINESS WIRE)--Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has been ...